05 August 2019

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

05 August 2019 | n=44

  1. Umlauf A, Soontornniyomkij B, Sundermann EE, Gouaux B, et al.
    Risk of developing cerebral beta-amyloid plaques with post-translational modification among HIV-infected adults.
    AIDS 2019.

  2. Le CN, Britto P, Brummel SS, Hoffman RM, et al.
    Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared to men.
    AIDS 2019.

  3. Requena S, Caballero E, Lozano AB, Rios-Villegas MJ, et al.
    Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain.
    AIDS 2019.

  4. Knudsen AD, Kofoed KF, Gelpi M, Sigvardsen PE, et al.
    Prevalence and risk factors of prolonged QT interval and electrocardiographic abnormalities in persons living with HIV.
    AIDS 2019.

  5. Meinck F, Pantelic M, Spreckelsen TF, Orza L, et al.
    Interventions to reduce gender-based violence among young people living with or affected by HIV/AIDS in low- and middle- income countries.
    AIDS 2019.

  6. French M.
    Antibody-mediated control of HIV-1 infection through an alternative pathway.
    AIDS 2019.

  7. Joska JA, Dreyer AJ, Nightingale S, Combrinck MI, et al.
    Prevalence of HIV-1 Infection in an elderly rural population and associations with neurocognitive impairment.
    AIDS 2019;33:1765-1771.

  8. Kouamou V, Manasa J, Katzenstein D, McGregor AM, et al.
    Drug resistance and optimizing dolutegravir regimens for adolescents and young adults failing antiretroviral therapy.
    AIDS 2019;33:1729-1737.

  9. Shahar E, Shapiro A, Baskin L, Oz ZK, et al.
    Antiretroviral therapy-induced negative HIV antibody test following diagnosis of HIV infection.
    AIDS 2019;33:1804-1805.

  10. Suzuki T, Uemura H, Yanagawa Y, Mizushima D, et al.
    Successful treatment for Kaposi sarcoma inflammatory cytokine syndrome in a severe CD4+ lymphocytopenic HIV patient.
    AIDS 2019;33:1801-1802.

  11. Brew BJ, Paul R.
    HIV-associated neurocognitive disorder, extracellular vesicles and gender: vive la difference?
    AIDS 2019;33:1795-1796.

  12. Sundermann E, Erlandson KM, Pope CN, Rubtsova A, et al.
    Current Challenges and Solutions in Research and Clinical Care of Older Persons Living with HIV: Findings Presented at the 9th International Workshop on HIV and Aging.
    AIDS Res Hum Retroviruses 2019.

  13. Zeballos D, Lins L, Brites C.
    FRAILTY AND ITS ASSOCIATION WITH HEALTH RELATED QUALITY OF LIFE IN OLDER HIV PATIENTS, IN SALVADOR, BRAZIL.
    AIDS Res Hum Retroviruses 2019.

  14. Levin J, Montano M.
    What Aging With HIV Means in the Year 2019.
    AIDS Res Hum Retroviruses 2019.

  15. Kasher Meron M, Xu S, Glesby M, Qi Q, et al.
    C1q/TNF-Related Proteins, HIV and HIV-associated Factors, and Cardiometabolic Phenotypes in Middle-Aged Women.
    AIDS Res Hum Retroviruses 2019.

  16. Arinze F, Gong W, Green AF, De Schacht C, et al.
    Immunodeficiency at Antiretroviral Therapy Start: Five Year Adult Data (2012-2017) Based on Evolving National Policies in Rural Mozambique.
    AIDS Res Hum Retroviruses 2019.

  17. Kojima N, Klausner JD.
    Disparities in the testing, treating, suppression, and prevention of HIV infection among underserved populations.
    AIDS Res Hum Retroviruses 2019.

  18. Brickman C, Propert K, Merlin J, Liu J, et al.
    Treatment and Outcomes of Oropharyngeal Cancer in Patients with Human Immunodeficiency Virus.
    AIDS Res Hum Retroviruses 2019.

  19. Safreed-Harmon K, Blach S, Aleman S, Boe Kielland K, et al.
    The Consensus Hepatitis C Cascade of Care: standardized reporting to monitor progress toward elimination.
    Clin Infect Dis 2019.

  20. Hocqueloux L, Gubavu C, Prazuck T, De Dieuleveult B, et al.
    Genital Human Immunodeficiency Virus-1 RNA and DNA Shedding in Virologically Suppressed Individuals Switching From Triple- to Dual- or Monotherapy: Pooled Results From 2 Randomized, Controlled Trials.
    Clin Infect Dis 2019.

  21. Lerner AM, Fauci AS.
    Opioid Injection in Rural Areas of the United States: A Potential Obstacle to Ending the HIV Epidemic.
    JAMA 2019.

  22. Giguere K, Behanzin L, Guedou FA, Talbot D, et al.
    PrEP Use Among Female Sex Workers: No Evidence for Risk Compensation.
    J Acquir Immune Defic Syndr 2019.

  23. Ascher SB, Scherzer R, Nishtala A, Jotwani V, et al.
    Association of Statin Use with Kidney Damage and Function Among HIV-infected Men.
    J Acquir Immune Defic Syndr 2019.

  24. Levy ME, Monroe AK, Horberg MA, Benator DA, et al.
    Pharmacologic Treatment of Psychiatric Disorders and Time with Unsuppressed HIV Viral Load in a Clinical HIV Cohort.
    J Acquir Immune Defic Syndr 2019.

  25. McManus WR, Bale MJ, Spindler J, Wiegand A, et al.
    HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy.
    J Clin Invest 2019;130.

  26. Muzny CA, Taylor CM, Swords WE, Tamhane A, et al.
    An Updated Conceptual Model on the Pathogenesis of Bacterial Vaginosis.
    J Infect Dis 2019.

  27. Massud I, Cong ME, Ruone S, Holder A, et al.
    Efficacy of oral tenofovir alafenamide/emtricitabine combination or single agent tenofovir alafenamide against vaginal SHIV infection in macaques.
    J Infect Dis 2019.

  28. Wahid B.
    Hepatotoxicity and virological breakthrough of HCV following treatment with sofosbuvir, daclatasvir, and ribavirin in patient previously treated for Tuberculosis.
    J Med Virol 2019.

  29. Alfadhli A, Staubus AO, Tedbury PR, Novikova M, et al.
    Analysis of HIV-1 matrix-envelope cytoplasmic tail interactions.
    J Virol 2019.

  30. Wu Y, Xue J, Wang C, Li W, et al.
    Rapid elimination of broadly neutralizing antibodies correlates with treatment failure in the acute phase of SHIV infection.
    J Virol 2019.

  31. Gach JS, Mara KJV, LaBranche CC, van Gils MJ, et al.
    Antibody responses elicited by immunization with BG505 trimer-immune complexes.
    J Virol 2019.

  32. Wensel D, Sun Y, Davis J, Li Z, et al.
    GSK3732394: A multi-specific inhibitor of HIV entry.
    J Virol 2019.

  33. Claiborne DT, Dudek TE, Maldini CR, Power KA, et al.
    Immunization of BLT Humanized Mice Redirects T Cell Responses to Gag and Reduces Acute HIV-1 Viremia.
    J Virol 2019.

  34. Rihn SJ, Aziz MA, Stewart DG, Hughes J, et al.
    TRIM69 inhibits Vesicular Stomatitis Indiana Virus (VSIV).
    J Virol 2019.

  35. Thans TVS, Akko JI, Niehrs A, Garcia-Beltran WF, et al.
    Primary HIV-1 strains use Nef to downmodulate HLA-E surface expression.
    J Virol 2019.

  36. Dentale N, Trisolini R.
    Respiratory Papillomatosis.
    N Engl J Med 2019;381:358.

  37. Anugulruengkitt S, Suntarattiwong P, Ounchanum P, Srirompotong U, et al.
    Safety of 6-week Neonatal Triple-combination Antiretroviral Postexposure Prophylaxis in High-risk HIV-exposed Infants.
    Pediatr Infect Dis J 2019.

  38. .
    Erratum for the Report: "Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells" by V. Ramsuran, V. Naranbhai, A. Horowitz, Y. Qi, M. P. Martin, Y. Yuki, X. Gao, V. Walker-Sperling, G. Q. Del Prete, D. K. Schneider,
    Science 2019;365.

  39. Cohen J.
    Once-a-year implant shows promise against HIV.
    Science 2019;365:309.

  40. Fabrizio C, Bavaro DF, Scudeller L, Lepore L, et al.
    Variability OF HIV-1 V2 env domain for integrin binding: Clinical correlates.
    Virology 2019;535:266-271.

  41. Collins TE, Nugent R, Webb D, Placella E, et al.
    Time to align: development cooperation for the prevention and control of non-communicable diseases.
    BMJ 2019;366:l4499.

  42. Alcorn K.
    HIV in 2019: it's all about dolutegravir.
    BMJ 2019;366:l4931.

  43. Mercer CH, Sonnenberg P, Woode-Owusu M, Clifton S, et al.
    Engage with the next wave of Britain's National Survey of Sexual Attitudes and Lifestyles.
    BMJ 2019;366:l4721.

  44. Iacobucci G.
    Depo-Provera: WHO set to review guidance on use by women at high HIV risk.
    BMJ 2019;366:l4888.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

09 December 2019

02 December 2019

25 November 2019

21 November 2019

11 November 2019


05 August 2019

Multidisciplinary Journal Club

  1. Ross JDC, Brittain C, Cole M, Dewsnap C, et al.
    Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
    Lancet. 2019 May 2. pii: S0140-6736(18)32817.

  2. Venter WDF, Moorhouse M, Sokhela S, Fairlie L, et al.
    Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV.
    N Engl J Med. 2019 Jul 24. doi: 10.1056/NEJMoa1902824.

  3. Chen N, Hao C, Liu BC, Lin H, et al.
    Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.
    N Engl J Med. 2019 Jul 24. doi: 10.1056/NEJMoa1901713.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016